Trial | NCT00874536  Report issue

Title

Omega-3 Supplementation and Attention-deficit-hyperactivity Disorder (ADHD)
The Effect of Omega-3 Fatty Acid Supplementation on Behavior of Children With ADHD

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    icosapent ethyl ...

  • Study Participants

    40
It is assumed that only 1/5 of children diagnosed with attention-deficit-hyperactivity disorder (ADHD) are treated. New treatment modalities are urgently needed. Omega-3 fatty acids have been used in this setting, yet results are conflicting. The parent omega-3 fatty acid alpha-linolenic acid (ALA) has only been used in one trial. 40 children diagnosed with ADHD will be randomized to consume either ALA or placebo for two months. Baseline and end assessments will include ADHD-related questionnaires and a computerized test. The investigators hypothesize that ALA supplementation will prove beneficial for children with ADHD.
Study Started
Apr 30
2009
Primary Completion
Jun 30
2011
Study Completion
Jun 30
2011
Last Update
Jul 30
2013
Estimate

Dietary Supplement omega-3 fatty acid alpha-linolenic acid (ALA)

3 grams of ALA-containing plant oil

Dietary Supplement Placebo

ALA Experimental

This group will receive the ALA supplement

Placebo Placebo Comparator

This group will receive the placebo supplement

Criteria 

Inclusion Criteria:

ADHD diagnosis
informed consent

Exclusion Criteria:

refusal of any testing
any comorbidities
any medication or supplement use
No Results Posted